A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of JSP191 for Hematopoietic Cell Transplantation Conditioning to Achieve Engraftment and Immune Reconstitution in Subjects With SCID

Disease Name

Severe Combined Immune Deficiency Syndrome (SCID)

Study Status

Date

April 25, 2023

Detail Link ( on-site link )

/phase-12-study-evaluate-safety-tolerability-and-efficacy-jsp191-hematopoietic-…